Transcription factor Sp1 is involved in the regulation of Varicella- zoster virus glycoprotein E

Virus Research

Volumn 69, Issue 1, 2000, Pages 69-81

  Rahaus, Markus ^a   Wolff, Manfred H ^a  

^a UNIVERSITY OF WITTEN HERDECKE   (Germany)

Author keywords

Cis trans interaction studies; Glycoprotein E; Sp1; TATA box binding protein; Varicella zoster virus

Indexed keywords

CIS ACTING ELEMENT; GLYCOPROTEIN E; GLYCOPROTEIN I; MESSENGER RNA; TATA BINDING PROTEIN; TRANSCRIPTION FACTOR SP1; UNCLASSIFIED DRUG; VIRUS DNA; VIRUS ENVELOPE PROTEIN; VIRUS GLYCOPROTEIN;

5' UNTRANSLATED REGION; ANIMAL CELL; ARTICLE; CELL STRAIN V 79; CONTROLLED STUDY; GENE FUNCTION; HUMAN; HUMAN CELL; IMMEDIATE EARLY GENE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DNA BINDING; REGULATORY MECHANISM; REPORTER GENE; TATA BOX; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION; VARICELLA ZOSTER VIRUS;

5' UNTRANSLATED REGIONS; BASE SEQUENCE; BINDING SITES; CELLS, CULTURED; DNA PRIMERS; DNA-BINDING PROTEINS; HERPESVIRUS 3, HUMAN; HUMANS; RNA, MESSENGER; RNA, VIRAL; SP1 TRANSCRIPTION FACTOR; TATA BOX; TATA-BOX BINDING PROTEIN; TRANSCRIPTION FACTORS; VIRAL ENVELOPE PROTEINS;

ANIMALIA; DNA VIRUSES; HUMAN HERPESVIRUS 3;

EID: 0034632646     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-1702(00)00180-5     Document Type: Article

References (46)

1. Arvin A.M., Solem S.M., Koropchak C.M., Kinney T.E., Paryani S.G. Humoral and cellular immunity to varicella-zoster virus glycoprotein gpI and to a non-glycosylated protein, p170, in the strain 2 guinea-pig. J. Gen. Virol. 68:1987;2449-2454.
2. Baudoux L., Defechereux P., Schoonbroodt S., Merville M.P., Rentier B., Piette J. Mutational analysis of varicella-zoster virus major immediate-early protein IE62. Nucleic Acids Res. 23:(8):1995;1341-1349.
3. Chiang C.M., Roeder R.G. Cloning of an intrinsic human TFIID subunit that interacts with multiple transcriptional activators. Science. 267:1995;531-536.
4. Choy B., Green M.R. Eukaryotic activators function during multiple steps of preinitiation complex assembly. Nature. 366:1993;531-536.
5. Cohen J.H., Straus S.E. Varicella-zoster virus and its replication. Fields B.N., Knipe D.M., Howley P.M. Fields' Virology. 2:1996;2525-2545 Lippincott-Raven, Philadelphia, PA.
6. Courey A.J., Tjian R. Analysis of Sp1 in vivo reveals multiple transcriptional domains, including a novel glutamine-rich activation motif. Cell. 55:1988;887-898.
7. Davison A.J., Scott J.E. The complete DNA sequence of varicella-zoster virus. J. Gen. Virol. 67:1986;1759-1816.
8. Defechereux P., Debrus S., Baudoux L., Rentier B., Piette J. Varicella-zoster virus reading frame 4 encodes an immediate-early protein with posttranscriptional regulatory properties. J. Virol. 71:1997;7073-7079.
9. Forghani B., Dupuis K.W., Schmidt N.J. Epitopes functional in neutralization of varicella-zoster virus. J. Clin. Microbiol. 28:1990;2500-2506.
10. Förster E. An improved general method to generate internal standards for competitive PCR. Biotechniques. 16:1994;18-20.
11. Hahn S., Buratowski S., Sharp P.A., Guarente L. Yeast TATA-binding protein TFIID binds to TATA elements with both consensus and nonconsensus DNA sequences. Proc. Natl. Acad. Sci. USA. 86:(15):1989;5718-5722.
12. Hardwicke M.A., Sandri-Goldin R.M. The herpes simplex virus regulatory protein ICP27 contributes to the decrease in cellular mRNA levels during infection. J. Virol. 68:(8):1994;4797-4810.
13. Hardy W.R., Sandri-Goldin R.M. Herpes simplex virus inhibits host cell splicing, and regulatory protein ICP27 is required for this effect. J. Virol. 68:(12):1994;7790-7799.
14. Hoey T., Dynlacht B.D., Peterson M.G., Pugh B.F., Tjian R. Isolation and characterization of the Drosophila gene encoding the TATA box binding protein, TFIID. Cell. 61:(7):1990;1179-1186.
15. Huang Z., Vafai A., Lee J., Mahalingam R., Hayward A.R. Specific lysis of targets expressing varicella-zoster virus gpI or gpIV by CD4-human T-cell clones. J. Virol. 66:1992;2664-2669.
16. Inchauspe G., Nagpal S., Ostrove J.M. Mapping of two varicella-zoster virus-encoded genes that activate the expression of viral early and late genes. Virology. 173:1989;700-709.
17. Intine R.V.A., Nazar R.N. PCR-mediated mutagenesis in sequences recalcitrant to homogeneous amplification. BioTechniques. 25:1998;364-366.
18. Jackson S.P., MacDonald J.J., Lees-Miller S., Tjian R. GC box binding induces phosphorylation of Sp1 by a DNA-dependent protein kinase. Cell. 63:(1):1990;155-165.
19. Jones K.A., Tjian R. Sp1 binds to promoter sequences and activates herpes simplex virus 'immediate-early' gene transcription in vivo. Nature. 317:1985;179-182.
20. Jones, K.A., K.R., Y., Tjian, R., 1985. Two distinct transcription factors bind to the HSV thymidine kinase promoter in vitro. Cell 42, 559-572.
21. Kadonaga J.T., Jones K.A., Tjian R. Promoter-specific activation of RNA polymerase II transcription by Sp1. Trends Biochem. Sci. 11:1986;20-23.
22. Khodarev N.N., Advani S.J., Gupta N., Roizman B., Weichselbaum R.R. Accumulation of specific RNAs encoding transcriptional factors and stress response proteins against a background of severe depletion of cellular RNAs in cells infected with herpes simplex virus 1. Proc. Natl. Acad. Sci. USA. 96:(21):1999;12062-12067.
23. Kim S., Yu S.S., Lee I.S., Ohno S., Yim J., Kang H.S. Human cytomegalovirus IE1 protein activates AP-1 through a cellular protein kinase(s). J. Gen. Virol. 80:(Pt 4):1999;961-969.
24. Kinchington P.R., Hougland J.K., Arvin A.M., Ruyechan W.T., Hay J. The varicella-zoster virus immediate-early protein IE62 is a major component of virus particles. J. Virol. 66:(1):1992;359-366.
25. Kinchington P.R., Vergnes J.P., Defechereux P., Piette J., Turse S.E. Transcriptional mapping of the Varicella-zoster virus regulatory genes encoding open reading frames 4 and 63. J. Virol. 68:1994;3570-3581.
26. Kwong A.D., Frenkel N. Herpes simplex virus-infected cells contain a function(s) that destabilizes both host and viral mRNAs. Proc. Natl. Acad. Sci. USA. 84:(7):1987;1926-1930.
27. Kwong A.D., Kruper J.A., Frenkel N. Herpes simplex virus virion host shutoff function. J. Virol. 62:(3):1988;912-921.
28. Lee W., Haslinger A., Karin M., Tjian R. Activation of transcription by two factors that bind promoter and enhancer sequences of the human metallothionein gene and SV40. Nature. 325:1987;368-372.
29. Ling P., Kinchington P.R., Sadeghi-Zadeh M., Ruyechan W.T., Hay J. Transcription from varicella-zoster virus gene 67 (Glycoprotein IV). J. Virol. 66:1992;3690-3698.
30. Litwin V., Grose C. Herpesviral Fc receptors and their relationship to the human Fc receptors. Immunol. Res. 11:(3-4):1992;226-238.
31. Mainka C., Fuss B., Geiger H., Hofelmayr H., Wolff M.H. Characterization of viremia at different stages of varicella-zoster virus infection. J. Med. Virol. 56:(1):1998;91-98.
32. McKnight S., Tjian R. Transcriptional selectivity of viral genes in mammalian cells. Cell. 46:1986;795-805.
33. Meier J.L., Luo X., Sawadogo M., Straus S.E. The cellular transcription factor USF cooperates with Varicella-zoster virus immediate-early protein 62 to symmetrically activate a bidirectional viral promoter. Mol. Cell. Biol. 14:1994;6896-6906.
34. Mo C., Suen J., Sommer M., Arvin A. Characterization of Varicella-Zoster virus glycoprotein K (open reading frame 5) and its role in virus growth. J. Virol. 73:(5):1999;4197-4207.
35. Nagpal S., Ostrove J.M. Characterization of a potent varicella-zoster virus encoded trans-repressor. J. Virol. 65:1991;5289-5296.
36. Perera L.P., Mosca J.D., Ruyechan W.T., Hay J. Regulation of varicella-zoster virus gene expression in human T lymphocytes. J. Virol. 66:(9):1992;5298-5304.
37. Rahaus M., Wolff M.H. Influence of different cellular transcription factors on the regulation of Varicella-zoster virus glycoproteins E (gE) and I (gI) UTR's activity. Virus Res. 62:(1):1999;77-88.
38. Sadzot-Delvaux C., Baudoux L., Defechereux P., Piette J., Rentier B. Overview of the replication cycle of varicella-zoster virus. Wolff M.H., Schünemann S., Schmidt A. Varicella-Zoster Virus: Molecular Biology, Pathogenesis and Clinical Aspects. Contributions to Microbiology. 3:1999;21-42 Karger, Basel.
39. Sambrook M.H., Fritsch E.F., Maniatis T. Molecular Cloning. A Laboratory Manual. 1989;Cold Spring Harbour Laboratory Press, New York.
40. Sandri-Goldin R.M., Hibbard M.K., Hardwicke M.A. The C-terminal repressor region of herpes simplex virus type 1 ICP27 is required for the redistribution of small nuclear ribonucleoprotein particles and splicing factor SC35; however, these alterations are not sufficient to inhibit host cell splicing. J. Virol. 69:(10):1995;6063-6076.
41. Sawadogo M., Roeder R.G. Interaction of a gene-specific transcription factor with the adenovirus major late promoter upstream of the TATA box region. Cell. 43:(1):1985;165-175.
42. Sawadogo M. Multiple forms of the human gene-specific transcription factor USF. II. DNA binding properties and transcriptional activity of the purified HeLa USF. J. Biol. Chem. 263:(24):1988;11994-12001.
43. Schek N., Bachenheimer S.L. Degradation of cellular mRNAs induced by a virion-associated factor during herpes simplex virus infection of Vero cells. J. Virol. 55:(3):1985;601-610.
44. Smale S.T. Transcription initiation from TATA-less promoters within eukaryotic protein-coding genes. Biochim. Biophys. Acta. 1351:(1-2):1997;73-88.
45. Strom T., Frenkel N. Effects of herpes simplex virus on mRNA stability. J. Virol. 61:(7):1987;2198-2207.
46. Zenzie-Gregory B., Khachi A., Garraway I.P., Smale S.T. Mechanism of initiator-mediated transcription: evidence for a functional interaction between the TATA-binding protein and DNA in the absence of a specific recognition sequence. Mol. Cell. Biol. 13:(7):1993;3841-3849.